Fairman Group »

Takeda Pharmaceutical shares owned by Fairman Group

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Fairman Group from 13F filings

Historical chart of Fairman Group investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Fairman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Fairman Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $625 45 13.89
2023-12-31 $642 45 14.27

More positions owned by Fairman Group

Accenture Plc Ireland Shs Class A (ACN)
Ishares Tr Core S&p500 Etf (IVV)
Accolade (ACCD)
Essent (ESNT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
W.R. Berkley Corporation (WRB)
Veeva Sys Cl A Com (VEEV)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Eafe Etf (EFA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)

View all positions for Fairman Group

Top funds holding Takeda Pharmaceutical

Mondrian Investment Partners
Millennium Management
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
Polygon Management
Van Eck Associates Corp.
Managed Asset Portfolios
Causeway Capital Management
Y.D. More Investments
Jane Street
Citadel Advisors
Bank of America Corporation
Wells Fargo & Company
Natixis Asset Management Advisors

View all funds holding Takeda Pharmaceutical